about
Aryl hydrocarbon receptor control of a disease tolerance defence pathwayDiagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward.Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.C-reactive protein in hypertension: clinical significance and predictive value.Hypercholesterolemia-associated endothelial progenitor cell dysfunction.Nutraceuticals for the treatment of hypercholesterolemia.The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors.Osteoanabolic therapy: a non-surgical option of treatment for Kümmell's disease?Lipoprotein(a): A missing culprit in the management of athero-thrombosis?Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias.A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease.Association between circulating osteoblast progenitor cells and aortic calcifications in women with postmenopausal osteoporosis.Long-term weight loss and blood pressure reduction: the perfect is the enemy of the good.Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.Postprandial endothelial impairment and reduced glutathione levels in postmenopausal women.Increased postprandial lipemia in patients with normolipemic peripheral arterial disease.miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease.Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia.Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism.Human endothelial impairment in sepsis.Prostaglandin E1 improves endothelial function in critical limb ischemia.Aortic stiffness in untreated adult patients with human immunodeficiency virus infection.Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia.Early vascular damage in primary hypoalphalipoproteinemia.Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women.Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia.Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures.Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia.Prognostic value of elevated white blood cell count in hypertension.Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension.Prognostic value of the metabolic syndrome in essential hypertension.Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia.Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women.Relevance of homocysteine on brachial flow-mediated vasodilatation and carotid and femoral intima-media thickness in patients with hypercholesterolemia.Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia.Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection.Determinants of the ambulatory arterial stiffness index regression line.Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival.
P50
Q33901562-A1FAF453-7238-4E4B-B33E-9D47484B1DB4Q35867888-82F5EC84-E9C9-4BDF-A4CC-0AFFFDDBB6F3Q35879522-F10C3853-1AAC-4964-BF82-2D3CB1637DC2Q36595963-66365B05-35EB-4B1E-96A7-E2B636713B72Q37362763-BB162890-2376-42E9-96E9-9AC20FE2624AQ38226567-85CDB120-B15C-4914-9556-9B891D715D6EQ39058419-CA7EAD77-B8EB-4886-B01C-D147DE3F4762Q39289069-78C1CFC5-986A-4AD5-AAC6-132BB6CDEC6BQ39368804-45DD8CA8-1EAC-4B67-934C-5C5C7B903612Q39443793-5A94F679-18E0-4AC5-87CA-6D8CD7205633Q40593450-49310D67-E88F-4912-A107-8A89672A99E1Q42247611-3FE58A7A-9628-47A9-8351-D03DFCD88892Q43724354-EBBD24B9-0023-4D48-B51F-CCB90FFA440DQ43770135-F3D98968-256F-4EB6-AC7F-7AD38C9FF296Q43889895-426EB06D-E72A-4DD7-B3B2-D41AEE2A935DQ43933297-D169859B-863A-4A82-8189-C1897E2F7D40Q43940554-D52C3F9B-A791-4005-A1D9-5742CFC0B282Q44020093-85C37569-0046-42C9-8772-759ED15EB52DQ44136346-BEF7E6AF-975C-4D08-8524-F518864A50C7Q44240757-739AA18C-A173-4844-9FA5-EA875015A594Q44283078-374CBFA7-3C68-424B-B434-C1B35AECAD20Q44291374-95822B17-5633-4E2A-8E89-ADD553E864E9Q44304893-C6AC9B9F-92C5-4011-865D-488808CD586EQ44341490-BBD3B009-CF42-4E8E-9599-2EA228465637Q44346408-CA005364-B125-4844-93A7-FCB443D753EBQ44368970-AEA45FF0-C0D9-4BED-84A4-E78136794FDEQ44582088-4F070D43-A7A8-4A01-8A26-391F199048FCQ44594446-39AC5548-84C6-426B-9BBF-BD41E72D463AQ44595496-34DA84FE-0948-4596-8C79-B4B16B199A89Q44665532-6064FB61-9CF2-4A6F-A428-994A3C1F2514Q44804601-C241595A-29A2-4D43-B5BB-30B00118CA63Q44838811-4D14FD7A-9A19-44F8-8EA3-C8F18BBFC9F2Q44897345-4978AD62-3C45-4F57-B7A3-F9F50C190ACEQ44898907-26259256-30B7-4398-9D21-BBA73334D7A7Q44911459-74C7417A-485E-41CA-B76A-ECE26307F78DQ44912699-89A3C258-AA9E-43EF-B928-F37B9E430E7FQ45173983-FFA27897-2DBA-4127-9F75-A81FBC23E351Q45424358-E81457A8-4727-40B7-B728-40E9B3CD1290Q45723354-85DA6709-AE64-478A-8EE1-F4A8F237BFD8Q45987659-DDD091F5-C500-4D4F-8966-DB93FCCBEC55
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matteo Pirro
@ast
Matteo Pirro
@en
Matteo Pirro
@es
Matteo Pirro
@nl
Matteo Pirro
@sl
type
label
Matteo Pirro
@ast
Matteo Pirro
@en
Matteo Pirro
@es
Matteo Pirro
@nl
Matteo Pirro
@sl
prefLabel
Matteo Pirro
@ast
Matteo Pirro
@en
Matteo Pirro
@es
Matteo Pirro
@nl
Matteo Pirro
@sl
P106
P1153
22036502300
P21
P31
P496
0000-0002-5527-4821